Business
ParamVerse Bio appoints Sushree Mishra as Chief of Strategy and Execution
ParamVerse Bio, a Mumbai company, has appointed Sushree Mishra as Chief of Strategy, Enterprise Initiatives and Execution. The company said the appointment strengthens its leadership team as it focuses on biotechnology expansion, strategic investments and new business opportunities. Mishra has nearly a decade of experience in corporate strategy and business transformation.
In the new role, she will work closely with the Founder's Office to identify emerging business opportunities and support the growth of the company's biotechnology platform. Her responsibilities include strategic capital allocation, new venture incubation, and enterprise-level planning and execution across several business verticals.
Before joining ParamVerse Bio, Mishra spent more than five years at JB Pharma, a KKR portfolio company, where she was Head of Global Corporate Strategy, Strategic Communications and In-Licensing. She is an alumna of Harvard Business School and has earlier worked at Cipla and Sarda Group. The report said the appointment reflects the company's emphasis on strategic execution and long-term growth in biotechnology and life sciences.
Key points
- ParamVerse Bio has appointed Sushree Mishra as Chief of Strategy, Enterprise Initiatives and Execution.
- Mishra will work with the Founder's Office to identify new business opportunities.
- Her responsibilities include strategic capital allocation and new venture incubation.
- She previously spent more than five years at JB Pharma, a KKR portfolio company.
- The company is focusing on biotechnology expansion, strategic investments and business diversification.
Coverage from
This story was put together automatically from the sources above. Open a source to read its original report. How nuze makes stories